HANGZHOU, China and SHAOXING, China, April 11, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) announces today that four clinical and preclinical study abstracts of NASH and HBV have been accepted by the International Liver Congress™ 2021 as poster presentations. The summary of the...
from PR Newswire: https://ift.tt/2PLHJdT
No comments:
Post a Comment